Amicus Therapeutics
Germany
Overview
Redefining Expectations in Rare Disease About Amicus Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Learn More About BioMarin We are guided by people living with rare diseases across the globe.
Company network
Hover or focus a node to highlight its relationships. Select a line to see what connects two objects.
Related companies share an industry or country with this company.
View relationships as a table
| From | To | What connects them |
|---|---|---|
| Amicus Therapeutics | Germany | IC360 lists Amicus Therapeutics in Germany. |
| 1. DC Deggendorf | Germany | IC360 lists 1. DC Deggendorf in Germany. |
| 1. FC 1906 Lichtenfels | Germany | IC360 lists 1. FC 1906 Lichtenfels in Germany. |
| 1. FC 1919 Mainstockheim | Germany | IC360 lists 1. FC 1919 Mainstockheim in Germany. |
| 1. FC 1921 Langfurth | Germany | IC360 lists 1. FC 1921 Langfurth in Germany. |
| 1. FC 1921 Winterhausen | Germany | IC360 lists 1. FC 1921 Winterhausen in Germany. |
